Skip to content

Blister Eradication Looking at Impact of Experimental Versus Established Regimens

Blister Eradication Looking at Impact of Experimental Versus Established Regimens

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03835806
Acronym
BELIEVER
Enrollment
130
Registered
2019-02-11
Start date
2019-04-27
Completion date
2022-08-31
Last updated
2021-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blister of Foot

Brief summary

The specific aim of this study is to evaluate whether RockTape has similar efficacy to Elastikon in the treatment of foot blisters in ultramarathon runners. Elastikon with paper tape and spray adhesive is a well-accepted means of blister treatment and has been used by medical staff at over 50 multi-stage ultramarathons around the world. RockTape is another commercially available product that has also been used by runners successfully to treat foot blisters. RockTape's adhesive qualities have a potential advantage over Elastikon, in that it does not require an additional adhesive substituting a level of complexity, weight, and cost for foot care. There have been no studies examining the efficacy of either agent for blister treatment. This randomized controlled trial will compare the traditional method of treating blisters with a multi-step approach of percutaneous drainage, paper tape, spray adhesive and then Elastikon to percutaneous drainage, paper tape and RockTape.

Detailed description

Friction foot blisters are one of the most common injuries encountered by hikers and runners(1) with incidence as high as 39% in marathoners(2). In adventure races it is the most commonly reported injury(3) and in expedition length ultramarathons, blisters account for nearly 74% of medical visits(4). While most blisters are of minor medical significance, they can impair concentration, decrease athletic performance, and can be potentially debilitating. The specific aim of this study is to evaluate whether RockTape has similar efficacy to Elastikon in the treatment of foot blisters in ultramarathon runners. Elastikon with paper tape and spray adhesive is a well-accepted means of blister treatment and has been used by medical staff at over 50 multi-stage ultramarathons around the world. RockTape is another commercially available product that has also been used by runners successfully to treat foot blisters. RockTape's adhesive qualities have a potential advantage over Elastikon, in that it does not require an additional adhesive substituting a level of complexity, weight, and cost for foot care. There have been no studies examining the efficacy of either agent for blister treatment. This randomized controlled trial will compare the traditional method of treating blisters with a multi-step approach of percutaneous drainage, paper tape, spray adhesive and then Elastikon to percutaneous drainage, paper tape and RockTape.

Interventions

OTHERElastikon

This randomized controlled trial will compare the traditional method of treating blisters with a multi-step approach of percutaneous drainage, paper tape, spray adhesive and then Elastikon which is our traditional blister treatment approach.

OTHERRocktape

This randomized controlled trial will compare the traditional method of treating blisters with a multi-step approach of percutaneous drainage, paper tape and then Rocktape which is our novel blister treatment approach.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

The treatments are visually dissimilar, therefore blinding for the investigator and subject is not possible.

Intervention model description

This is a randomized control trial looking at a novel blister treatment intervention versus a traditional model.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* The study enrollment period will run for approximately 7 days over 3 weeks throughout 2019 at Racing the Planet races in Namibia, Mongolia and Chile. All racers are potential subjects. Subjects will be enrolled when they present to the medical tent for the treatment of their first painful blister. The subject will be evaluated for

Exclusion criteria

and the subject will be asked to select the most painful blister to be included in the study. All other blisters may be treated through traditional means and are not included in the study.

Design outcomes

Primary

MeasureTime frameDescription
Treatment successData will be collected during the 1 week ultramarathon in austere conditions until study completion, usually 3-5 days. This will be conducted over 3 separate races.The subject's involvement in the study will end in one of the following situations and the researcher will fill out the appropriate data sheet at the time of the subject's departure from the study. 1. The blister treatment is a success as defined by: 1. the blister treatment falls off and the subject has no pain and no blister reoccurrence 2. the blister treatment is removed by the subject and does not need to be replaced because the there is no pain or blister present 3. the blister treatment stays on for the length of the study needing no intervention 2. The blister treatment is a failure as defined by: 1. if the blister re-occurs 2. if the treated area has pain to the point that the blister treatment must be removed to evaluate 3. if the subject removes the blister treatment and needs to be retreated. 3. The race has come to completion 4. The subject withdraws from the race or the study.

Countries

Chile, Mongolia, Namibia

Contacts

Primary ContactPatrick B Burns, MD
pburns@stanford.edu9788663533
Backup ContactGrant Lipman, MD
gslipman@stanford.edu4152909286

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026